Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PrEP for HIV prevention in Western Australia (PrEPIT-WA)
NCT03327155Phase 3Completed
- Sponsor
- The Kirby Institute
- Start
- Nov 2017
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tenofovir disoproxil fumarate, emtricitabine in human immunodeficiency virus infection (HIV), sponsored by The Kirby Institute. Started Nov 2017; status: completed.
02
Drugs
tenofovir disoproxil fumarateemtricitabine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT03327155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03327155.